10 Best Tech Stocks To Own For 2014

It's fair to say that companies involved in the natural gas cycle are affected in different ways when the price of the gaseous fossil fuel ebbs and flows. Halliburton (NYSE: HAL  ) is a company that benefits indirectly from higher natural gas prices because its customers are more likely to increase drilling activity in this state. Being respected as the leader in fracking technology bodes well for Halliburton should natural gas rig count activity rebound in tandem with market prices.�

For a company that stands to delight investors in this scenario because its resource base will appreciate dramatically, turn to EQT (NYSE: EQT  ) . Encompassing multiple points along natural gas' lifeline, a rise in prices will undoubtedly lead to an increase in the bottom line of this low-cost Marcellus operator. For more details on each company's operations and how they stand to benefit from the rise in nat-gas prices, tune in below.

Top 5 Casino Stocks To Watch Right Now: Comverse Inc (CNSI)

Comverse, Inc. (CNS), incorporated on November 19, 1997, is a provider of software and systems enabling services for converged billing and active customer management, mobile Internet, and value-added services. The Company�� product portfolios includes value added services, billing and active customer management, and mobile Internet. The Company�� offerings include Comverse ONE, Comverse VAS, Comverse mobile Internet and Comverse global services.

The Company�� ONE deployment modes include Comverse ONE converged billing and active customer management, Comverse ONE real-time billing, Comverse ONE postpaid billing & active customer management, Comverse ONE online and converged charging, and create ONE of your own solutions. CNS is a wholly owned subsidiary of Comverse Technology, Inc.

Advisors' Opinion:

• [By Lisa Levin]

  Comverse (NASDAQ: CNSI) shares fell 2.50% to reach a new 52-week low of $25.75. Comverse's trailing-twelve-month profit margin is 2.86%.

  Posted-In: 52-Week LowsNews Movers & Shakers Intraday Update Markets

10 Best Tech Stocks To Own For 2014: Taro Pharmaceutical Industries Ltd (TARO)

Taro Pharmaceutical Industries Ltd., incorporated in 1959, is a science-based pharmaceutical company. The Company develops manufactures, and markets prescription and over-the-counter (OTC) pharmaceutical products, primarily in the United States, Canada and Israel. The Company also develops and manufactures active pharmaceutical ingredients (APIs), primarily for use in its finished dosage form products. The Company�� primary areas of focus include pediatric creams and ointments, liquids, capsules and tablets, mainly in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The Company operates through three companies: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries (including indirect), Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets more than 180 pharmaceutical products in over 25 countries.

Taro Israel manufactures more than 160 finished dosage form pharmaceutical products for sale in Israel and for export. It produces APIs used in the manufacture of finished dosage form pharmaceutical products. It markets and distributes generic products in the local Israeli market. Taro Israel�� primary product lines include dermatology, prescription and OTC semi-solid products (creams, ointments and gels) and liquids; cardiology and neurology, prescription oral dosage products; oral analgesics, both prescription and OTC, and OTC oral and nasal sprays and ophthalmic products.

Taro Canada manufactures more than 70 finished dosage form pharmaceutical products for sale in Canada and for export. It markets and distributes generic products in the local Canadian market. Its product line includes dermatology: prescription and OTC semi-solid products (creams, ointments and gels) and liquids, cardiology, oncology, gastrointestinal and neurology: prescription oral and injects able dosage products, and allergy (antihistamine): OTC oral dosage products.

Taro U.S.A markets! and distributes generic products in the United States market. Its primary product lines include dermatology: prescription and OTC semi-solid products (creams, ointments and gels) and liquids, cardiology and neurology: prescription oral dosage products, and other prescription and OTC products.

The Company competes with Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer/Wyeth, Valeant, Galderma, Merck/Schering-Plough, Teva Pharmaceuticals U.S.A., Mylan Laboratories, Perrigo Company, Ranbaxy Pharmaceuticals Inc., Sandoz Pharmaceuticals, Merck Canada Inc., Pfizer Canada Inc., Janssen Inc., Schering-Plough Canada, Novartis Pharmaceuticals Canada Inc., GlaxoSmithKline Inc., Bayer Inc., Bristol-Myers Squibb Canada, Apotex Inc., Teva Canada Limited, Mylan Pharmaceuticals ULC, Sandoz Canada Incorporated, Pharmascience Inc., Teva Pharmaceutical Industries Ltd., Perrigo Israel Pharmaceuticals Ltd., Dexxon Ltd., Rafa Laboratories Ltd., Bayer AG, Eli Lilly and Company, Merck & Co., Inc. and Pfizer Inc.

Advisors' Opinion:

• [By Ben Levisohn]

  Teva has dropped 7.7% to $37.85 today at 3:23 p.m. but doesn’t seem to be spreading though the generic drug space. Taro Pharmaceuticals (TARO) ha gained 1.1% to $79, while Actavis (ACT) has gained 1.2% to $156.25 and Dr. Reddy’s Laboratories (RDY) has advanced 1% to $40.24. Mylan (MYL) has dropped 0.7% to $38.40.

• [By Rich Smith]

  Israeli drugmaker Taro Pharmaceutical Industries (NYSE: TARO  ) has a new CEO -- and a new Chairman of the Board, as well.

  On Thursday, Taro announced the imminent retirement of Interim Chief Executive Officer Mr. James Kedrowsk, who will be replaced August 1 by new permanent CEO Mr. Kalyanasundaram Subramanian ("Kal Sundaram"). Additionally, the company said that Dilip Shanghvi�has been appointed Chairman of its Board of Directors.

10 Best Tech Stocks To Own For 2014: CEVA Inc.(CEVA)

CEVA, Inc., together with its subsidiaries, engages in licensing silicon intellectual property (SIP) for the handsets, mobile broadband, portable, and consumer electronics markets primarily in the United States, Europe, the Middle East, and the Asia Pacific. It designs and licenses DSP cores in the form of a hardware description language definition; a portfolio of application-specific platforms, including wireless baseband, audio, imaging and vision, voice over Internet protocols (VoIP), Bluetooth, and serial storage technology and serial attached SCSI; and development platforms, software development kits, and software debug tools that facilitate system design, debug, and software development. The company?s intellectual property (IP) is used by semiconductor and original equipment manufacturer companies for application-specific integrated circuits and application-specific standard products. It serves various markets, including feature phones, smartphones, machine to machi ne for various cellular standards, home entertainment, portable game consoles, and serial storage and telecommunication devices. CEVA, Inc. markets its technology through a direct sales force. The company was formerly known as ParthusCeva, Inc. and changed its name to CEVA, Inc. in December 2003. CEVA, Inc. was founded in 1999 and is headquartered in Mountain View, California.

Advisors' Opinion:

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on CEVA (Nasdaq: CEVA  ) , whose recent revenue and earnings are plotted below.

10 Best Tech Stocks To Own For 2014: Imprimis Pharmaceuticals Inc (IMMY)

Imprimis Pharmaceuticals Inc. is a specialty pharmaceutical company developing non-invasive, topically delivered products. The Company�� Transdel cream formulation technology is designed to facilitate the effective penetration of a variety of products through the tough skin barrier. Ketotransdel, the Company�� lead pain product, utilizes the Transdel platform technology to deliver the active drug, ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), through the skin directly into the underlying tissues where the drug exerts its anti-inflammatory and analgesic effects. Ketotransdel consists of a transdermal formulation of ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), and its Transdel drug delivery system and is being developed for the treatment of acute pain. In July 2013, it acquired intellectual property for IPI-120 from Buderer Drug Company.

Ketotransdel penetrates the skin barrier to reach the targeted underlying tissues where it exerts its localized anti-inflammatory and analgesic effect. Transdel is the Company�� transdermal cream drug delivery platform. It consists of a cream that enables transdermal penetration of drugs avoiding first pass metabolism by the liver and minimizing systemic exposure. The Transdel drug delivery system facilitates the effective dissolution and delivery of a drug across the skin barrier to reach targeted underlying tissues.

Advisors' Opinion:

• [By John Udovich]

  So far this year, Rexahn Pharmaceuticals, Inc (NYSEMKT: RNN), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and Arrowhead Research Corp (NASDAQ: ARWR) are up 186.3%, 157.2% and 142.5%, respectively, since the start of the year���making them the best performing small cap biotech stocks for 2014. But given their lackluster performance over the past few years, what is the secret behind their phenomenal 2014 rise and will they keep rising? For starters, none of these small caps have really produced anything in the way of blockbuster news:

10 Best Tech Stocks To Own For 2014: IZEA Inc (IZEA)

IZEA, Inc. (IZEA), formerly IZEA Holdings, Inc., incorporated in February 2006, is a marketplace for consumer generated advertising, connecting advertisers with social media publishers, such as bloggers, tweeters and others in order to develop and distribute content throughout the blogosphere and social networks. The Company is a social media sponsorship, operating multiple marketplaces, which include WeReward, SponsoredTweet, SocialSpark, PayPerPost and InPostLinks. It generates its revenue through the sale of social media sponsorships (SMS) to its customers. Each platform the Company operates is designed to facilitate SMS transactions. Each platform provides advertisers with access to a network of publishers, workflow management, content control, payment processing, performance tracking and legal compliance. It has more than 50,000 registered advertisers in 157 different countries. Its publishers publish sponsored content to blogs, Twitter, Facebook and Foursquare and reach other existing platforms, such as Tumblr, LinkedIn, Google and Bing through syndication of that content. On May 12, 2011, the Company acquired IZEA Innovations, Inc. In December 2012, the Company acquired Twitter marketing platform FeaturedUsers.

During the year ended December 31, 2011, the Company derived 80% its revenue from advertisers for the use of its network of social media publishers to fulfill an advertiser sponsor requests for a blog post, tweet, click, purchase, or action. During 2011, it derived the remaining 20% revenue from various service fees charged to advertisers and publishers. Service fees to advertisers include fees charged for management of advertising campaigns through its platforms and inactivity fees for dormant accounts. Service fees to publishers include upgrade account fees for obtaining greater visibility to advertisers in advertiser searches in its platforms and inactivity fees for dormant accounts.

SocialSpark

SocialSpark is the Company�� blog marketing platf! orm. Through SocialSpark it provides robust targeting and detailed analytics to advertisers. The site allows advertisers to develop lists of blogs based on various criteria, such as relevancy, traffic and demographic data. The platform also enables advertisers to create social media campaigns with the click of a button and to observe campaign results in real time. SocialSpark is also used by brands interested in engaging in conversations with their consumer bases. This platform is an automated, scalable version of other blogger outreach services conducted by public relations agencies, such as Porter Novelli, Edelman and Ketchum.

SponsoredTweets

SponsoredTweets is an online marketplace, which allows consumers to connect directly with advertisers to engage in sponsored conversations through Twitter. Marketers pay for Twitter advertising campaigns on either a cost per tweet (CPT) or cost per click (CPC) basis. SponsoredTweets allows advertisers to hand pick individual tweeters, including celebrities, to participate in Twitter advertising campaigns.

WeReward

WeReward is a social-mobile incentive platform, which allows brands to drive purchases, reward loyalty and understand their customers. WeReward promotes businesses, consumer products and mobile applications through its application, which can be downloaded on iPhone and Android devices. Consumers are able to earn WeReward points at more than 15 million businesses in the United States. WeReward points act as a cash rebate through PayPal to create value for users. This platform is similar to CheckPoints.

PayPerPost and InPostLinks

PayPerPost and InPostLinks are online marketplaces designed to facilitate search engine and allow advertisers to connect directly with bloggers to develop relevant blog post content and place text link advertising within blog posts. Both systems allow advertisers to compensate bloggers with cash in exchange for content and links back to Websites.

! IZEAMedia and Staree

IZEAMedia (in Pilot) allows advertisers to place display advertising next to sponsored blog content. Staree (in Development) is an online platform designed to help celebrities better monetize multimedia content through SMS.

The Company competes with Facebook, Glam Media, Federated Media, BlogHer, Ad.ly, Mom Central, Foursquare and Groupon.

Advisors' Opinion:

• [By Peter Graham]

  Small cap tech, mobile or cloud computing stocks SofTech, Inc (OTCMKTS: SOFT), Firstin Wireless Technology Inc (OTCMKTS: FINW) and Izea Inc (OTCMKTS: IZEA) have been getting some extra attention lately in various investment newsletters or alerts. That�� because at least one of these stocks appears to be the subject of paid third party promotions while another is the focus of an apparent investor relations campaign. Keeping that in mind, are these three tech orientated stocks going to bring profits to investors and traders or bring out the luddite in them? Here is a closer look:

10 Best Tech Stocks To Own For 2014: Sunedison Inc (SUNE)

SunEdison Inc, formerly MEMC Electronic Materials, Inc., incorporated on October 1, 1984, is engaged in the development, manufacture and sale of silicon wafers. The Company is a developer and seller of photovoltaic energy solutions. Through Solar Materials and Solar Energy (SunEdison), it is a developer of solar energy projects. The Company operates in two segments: semiconductor materials and solar energy. The Company�� Solar Energy segment includes the operations of its old Solar Materials segment, as well as its SunEdison business. In the Semiconductor Materials, the Company offers wafers with a variety of features. The Company�� wafers vary in size, surface features, composition, purity levels, crystal properties and electrical properties.

Semiconductor Materials

The Company�� monocrystalline wafers for use in semiconductor applications range in size from 100 millimeter to 300 millimeter and are round in shape for semiconductor customers because of the nature of their processing equipment. Its wafers are used as the starting material for the manufacture of various types of semiconductor devices, including microprocessor, memory, logic and power devices. In turn, these semiconductor devices are used in computers, cellular phones and other mobile electronic devices, automobiles and other consumer and industrial products. Its monocrystalline wafers for semiconductor applications include four general categories of wafers: prime, epitaxial, test/monitor and silicon-on-insulator (SOI) wafers.

The Company�� prime wafer is a polished, pure wafer with an ultraflat and ultraclean surface. The Company�� epitaxial (epi), wafers consist of a thin silicon layer grown on the polished surface of the wafer. Typically, the epitaxial layer has different electrical properties from the underlying wafer. This provides customers with isolation between circuit elements than a polished wafer. Its AEGIS product is designed for certain specialized applications requiring high resis! tivity epitaxial wafers and its MDZ product feature. The AEGIS wafer includes a thin epitaxial layer grown on a standard starting wafer. The AEGIS wafer�� thin epitaxial layer eliminates harmful defects on the surface of the wafer, thereby allowing device manufacturers to increase yields. The Company supplies test/monitor wafers to its customers for use in testing semiconductor fabrication lines and processes. An SOI wafer is a different starting material for the chip making process.

Solar Energy

The Company�� Solar Energy segment provides solar energy services that integrate the design, installation, financing, monitoring, operations and maintenance portions of the downstream solar market to provide a solar energy service to its customers. As of December 31, 2012, SunEdison interconnected over 675 solar power systems representing 989 megawatt of solar energy generating capacity. As of December 31, 2012, SunEdison had 73 megawatt of projects under construction and 2.6 gigawatts in pipeline. In support of its downstream solar business, its Solar Energy segment manufactures polysilicon, silicon wafers and solar modules. Additionally, its Solar Energy segment will sell solar modules to third parties in the event the opportunity aligns with itsinternal needs. It provides its downstream customers with a way to purchase renewable energy by delivering solar power under long-term power purchase arrangements with customers or feed-in tariff arrangements with government entities and utilities. Its SunEdison business is dependent upon government subsidies, including United States federal incentive tax credits, state-sponsored energy credits and foreign feed-in tariffs. The Company�� solar wafers are used as the starting material for crystalline solar cells.

The Company competes with Shin-Etsu Handotai, SUMCO, Siltronic and LG Siltron, SunPower Corporation, First Solar, Inc., Enerparc, Sharp Corporation (Recurrent Energy), Phoenix Solar, BELECTRIC, JUWI Solar Gmbh, and S! olar City! .

Advisors' Opinion:

• [By Rich Smith]

  MEMC (NYSE: SUNE  ) isn't MEMC anymore.

  Late last week, MEMC Electronic Materials confirmed that it will officially change its name to SunEdison today and adopt the "SUNE" ticker symbol for itself. Stockholder support for the change was said to be "overwhelming."

• [By Paul Ausick]

  SunEdison Inc. (NYSE: SUNE), like SunPower, has had a booming year. The share price is up more than 265% in the past 12 months. Shares closed at $14.01 Monday night, in a 52-week range of $3.64 to $14.71. With a price target of around $15.20, the potential upside is nearly 8%. Expected 2014 EPS is $0.56, and the stock’s forward P/E ratio is around 25. The company is planning to spin off its semiconductor wafer business during the first quarter.

• [By Paul Ausick]

  Another possible target is the solar energy division of SunEdison Inc. (NYSE: SUNE). The company said last week that it would be spinning off its semiconductor business into a separate company next year. In the second quarter of this year the semiconductor segment provided about 60% of SunEdison�� total revenues of $401.3 million. But the company�� solar business has historically provided most of the revenues and could be both a target as operating losses in the solar energy segment continue.

10 Best Tech Stocks To Own For 2014: Convergys Corporation (CVG)

Convergys Corporation provides relationship management solutions in North America and internationally. Its Customer Management segment offers agent-assisted, self-service, and intelligent technology care solutions, including customer service, customer retention, sales, technical support, social interaction, collections management, back office, business-to-business, customer experience applied analytics, and intelligent interaction solutions for communications, financial services, technology, retail, healthcare, and government markets. This segment also provides premise-based and hosted automated self-care and technology solutions; speech recognition solutions; and license, professional, consulting and maintenance, and software support services. Convergys Corporation was founded in 1998 and is headquartered in Cincinnati, Ohio.

Advisors' Opinion:

• [By Wallace Witkowski]

  Convergys (CVG) �shares surged 20% to $25 on light volume after the customer management firm announced it will acquire Stream Global Services Inc. for a total enterprise value of $820 million in cash. The acquisition should add about 35 cents a share to Convergys earnings excluding one-time costs, the company said.

• [By Jake L'Ecuyer]

  Convergys (NYSE: CVG) was also up, gaining 12.44 percent to $23.46 after the company announced its plans to acquire Stream Global Services for $820 million in cash. Convergys also reaffirmed its outlook for 2013.